Table 1.
Patient and tumor characteristics
| N (%) | |
|---|---|
| Age (years) | |
| Median (range) | 31 (14–62) |
| Primary site of origin | |
| Testicular | 52 (83) |
| Mediastinal | 11 (17) |
| IGCCG Risk Group | |
| 1 | 5 (8) |
| 2 | 13 (21) |
| 3 | 45 (71) |
| Metastatic to brain at diagnosis | |
| Yes | 15 (24) |
| No | 48 (76) |
| Metastatic involvement at time of brain relapse | |
| Lung | 41 (63) |
| Liver | 21 (33) |
| Bone | 8 (13) |
| Brain | 63 (100) |
| Number of brain metastases | |
| 1 | 14 (22) |
| 2–5 | 33 (52) |
| >5 | 16 (25) |
| Size of largest brain metastases (cm) | |
| Median (range) | 1.8 (0.4–6.3) |
| Surgery for brain metastases | |
| Yes | 16 (25) |
| No | 47 (75) |
| Chemotherapy for treatment of brain metastases | |
| Concurrent | 11 (17) |
| Before RT | 14 (22) |
| After RT | 10 (16) |
| Radiation field | |
| WBRT | 45 (71) |
| SRS | 7 (11) |
| WBRT + SRS / Cone-down | 9 (14) |
| Partial brain | 1 (2) |
| No RT | 1 (2) |